Loading...
Gut Microbiota and Response to Immunotherapeutic Drugs in Oncology: More Questions Than Answers
Immuno-oncology drugs (IODs) have revolutionized the treatment of some cancers. Although IODs are enabling some patients with cancer to become long-time survivors, only 30% to 40% respond to these drugs. There is experimental and clinical evidence that the gut microbiome may play a role in IOD respo...
Na minha lista:
| Udgivet i: | Clin Med Insights Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7376376/ https://ncbi.nlm.nih.gov/pubmed/32742177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179554920933868 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|